TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease

Medicine and Dentistry

• Lipid Diet 100%
• Plasminogen Activator Inhibitor-1 83%
• Therapeutic Procedure 83%
• Nonalcoholic Fatty Liver 66%
• Tumor Necrosis Factor 33%
• Fibrosis 16%
• Serositis 16%
• Insulin Resistance 16%
• Obesity 16%
• Gene Expression 16%
• Therapy Effect 16%
• Fatty Liver 16%
• Water-Electrolyte Imbalance 16%
• Insulin Sensitivity 16%
• Mitochondrial Biogenesis 16%
• Cells 16%

Biochemistry, Genetics and Molecular Biology

• Fat 100%
• Plasminogen Activator Inhibitor-1 83%
• Mouse 33%
• Insulin Resistance 16%
• Gene Expression 16%
• Glucose 16%
• C57BL 6 Mouse 16%
• Metabolic Disorder 16%
• Insulin Sensitivity 16%
• Mitochondrial Biogenesis 16%
• In Vivo Study 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Plasminogen Activator Inhibitor 1 83%
• Nonalcoholic Fatty Liver 66%
• Mouse 33%
• C57BL 6 Mouse 16%
• Fibrosis 16%
• Obesity 16%
• Insulin Resistance 16%
• Fatty Liver 16%
• Metabolic Disorder 16%
• Glucose Intolerance 16%